AIT-082 Phase 1B Study
NCT00000180
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
NIH
Sponsor class
Conditions
Memory Disorders
Interventions
DRUG:
AIT-082
Sponsor
National Institute on Aging (NIA)